AEON Biopharma

AEON34

Penny Stock

$0.68arrow_drop_up2.98%$0.02

Penny Stock

AEON34

$0.68

arrow_drop_up2.98%$0.02

Penny Stock

Performance History

Key Stats
Open	$0.70
Prev. Close	$0.66
EPS	-0.14
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-
Market Cap	$27.22M
PE Ratio	-

	LOW	HIGH
Day Range	0.63	0.71
52 Week Range	0.63	17.17

Ratios

Revenue	-



EBITDA Margin %	-

EPS	-0.14

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About AEON Biopharma (AEON)

AEON Biopharma, Inc. (AEON) is a pharmaceutical company specializing in the development of innovative drug therapies. With a strong focus on biotechnology, AEON aims to revolutionize the healthcare industry through groundbreaking research and cutting-edge technologies. Over the years, AEON has established itself as a leader in the field, with a portfolio of promising drug candidates that have the potential to address unmet medical needs and improve patient outcomes.

One of the key strengths of AEON is its commitment to scientific excellence. The company's team of world-class researchers and scientists work tirelessly to advance the understanding of disease mechanisms and develop novel treatment approaches. By leveraging their expertise in areas such as genomics, proteomics, and bioinformatics, AEON is able to identify promising drug targets and design innovative therapies that have the potential to make a significant impact.

Websitecall_made

Sector: Healthcare
Industry: Biotechnology
CEO: Mr. Marc Forth
Headquarters: Irvine
Employees: 8
Exchange: NYSE

Keep an eye on AEON Biopharma

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is the 52-week high and low for AEON Biopharma (AEON)?

For AEON Biopharma (AEON), the 52-week high is $17.17, which is 2.39K% from the current price. The 52-week low is $0.64, the current price is 8.33% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

What is AEON Biopharma's (AEON) price per share?

The current price per share for AEON Biopharma (AEON) is $0.69. The stock has seen a price change of $0.02 recently, indicating a 2.99% change. This reflects the stock's recent market performance and investor sentiment.

help

Is AEON Biopharma (AEON) a growth stock?

AEON Biopharma (AEON) has shown an average price growth of 0.41% over the past three years. It has received a score of 0 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying AEON Biopharma as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is AEON Biopharma (AEON) stock price performance year to date (YTD)?

As of the latest data, AEON Biopharma (AEON) has a year-to-date price change of -90.73%. Over the past month, the stock has experienced a price change of -29.69%. Over the last three months, the change has been -36.79%. Over the past six months, the figure is -93.68%.

help

Is AEON Biopharma (AEON) a profitable company?

AEON Biopharma (AEON) has a net income of -$52.56M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. Operating income is noted at -$48.43M. Furthermore, the EBITDA is -$43.86M.

help

What is the market capitalization of AEON Biopharma (AEON)?

AEON Biopharma (AEON) has a market capitalization of $27.23M. The average daily trading volume is 108.08K, indicating the stock's liquidity and investor engagement.